Precision for Medicine

Ready for a new challenge? Senior Financial Analyst: hubs.ly/Q047JnHl0 Director, Project Management (Canada): hubs.ly/Q047JlRz0

Precision CMAC highlights include Jing Ping Yeo on an expert panel discussion on global strategy & value creation for small‑molecule drug development, and being recognized as a CMAC Outstanding Win‑Win Partner. If you’re still onsite today, stop by Booth EO4 to meet our team.

As AI moves from experiment to expectation, the EMA and FDA published 10 joint principles for AI across the drug development lifecycle. This signals that regulators now view AI-enabled methods as part of the core regulatory environment. Dive deeper: hubs.ly/Q047vPqj0

We're at CMAC China Booth EO4. Explore how our global clinical & biomarker‑driven solutions help advance innovative therapies, empower Chinese biopharma companies with global development pathways, and bring access to China’s investigator site network to sponsors worldwide.

For sponsors focused on first‑in‑human and proof‑of‑concept, the space has grown complex, with biomarker layers, global site networks, diverse mechanisms & more. We outline how to navigate this uncertainty and position your early program for momentum: hubs.ly/Q047k3vZ0

FDA’s updated guidance is a blueprint for sponsors who want to design trials that can reflect U.S. patients, withstand scrutiny, and deliver meaningful outcomes. We’ve distilled the latest thinking into six actionable takeaways. hubs.ly/Q047593s0

We're excited to return as a sponsor of PHUSE US Connect 2026. For the second year in a row, we’re delighted to sponsor the Sip & Paint social event. If you’ll be at PHUSE US Connect, we’d love to connect. Visit us throughout the week or reach out to schedule time with our team.

Seeking Senior Project Managers who are looking to have influence and impact when it matters most. hubs.ly/Q046HdCv0

Strategic regulatory pivots, adaptive feasibility modeling, targeted investigator engagement & coordinated operational execution stabilized & expanded this global first-line oncology study, achieving sustained, accelerated enrollment across 16 countries. hubs.ly/Q046wvHP0

Our new office in Tokyo marks the most recent expansion of Precision’s global footprint in APAC. Precision’s regional presence now includes Mainland China, Hong Kong, Singapore, India, South Korea, Taiwan and Australia. Read the press release here: hubs.ly/Q046l6Kp0?

In Healthcare Brew’s latest piece, Nicholas Richardson highlights how improved real‑world data and alternative evidence sources are helping make the FDA’s shift to single pivotal trials more feasible. hubs.ly/Q0469myj0?

We invite you to meet with our APAC leadership at CMAC to discuss early clinical strategy, operational excellence, and global capabilities. Visit the team at Booth E04 to connect. Contact us to reserve a meeting time here hubs.ly/Q04673Gp0

Avoid queries from health authorities with a meticulously planned and executed ISS & ISE. Ensure your data tells a compelling, coherent story that meets strict regulatory standards: hubs.ly/Q045_GHF0

Could Australia unlock APAC trial acceleration? We'll be at the Austrade Clinical Trials Partnership Forum, held alongside Clinical Trials Festival Asia in Singapore! James Cheong's presentation will discuss Australia’s regulatory pathways for clinical trial development.

Help create a brighter tomorrow. Director, Project Mgmt (Canada): hubs.ly/Q045S2Lt0 Medical Director (Autoimmune): hubs.ly/Q045S7FH0 Op Strategy Director: hubs.ly/Q045S31d0 Sr Financial Analyst: hubs.ly/Q045S79Q0 Sr Project Mgr: hubs.ly/Q045S1hR0

If you are building trials across APAC and beyond, and want to move faster with fewer handoffs, let’s connect. We will be on site in Singapore to meet and share insights into multi-regional trials in both Eastern and Western markets. Reach out to schedule a meeting.

In a conversation with Dr. Emiliano Calvo Aller, President of START Europe, we uncovered what it actually takes to move innovative oncology treatments from development to real‑world patient access and why partnership matters at every step of that journey. hubs.ly/Q045HJFH0

At CMAC 2026, Jing Ping Yeo will share practical insights on operational challenges, study‑level decision‑making, and clinical‑operational approaches to improving development efficiency and global readiness. Reserve your meeting time with us here: hubs.ly/Q045DR6c0

Last week our CMO Harpreet Singh, MD, joined Fierce Pharma’s The Top Line podcast to discuss how the FDA is approaching CAR-T therapies in autoimmune disease. Hear Harpreet’s perspective on how sponsors can navigate this evolving regulatory landscape. hubs.ly/Q045y5Gx0?

Precision's own Vicky Hunnam and David Bird had a great first day at COG UK, catching up with industry peers, deepening connections and making new ones. Reach out to Vicky or David to arrange time to talk. #COGUK